Showing results (51-60 of 227) with videos related to

Sort By:
Pageof 23
Diagnostics (Basel, Switzerland)|March 11, 2023
Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen SignalingFlorian Weber, Susanne Schueler-Toprak, Christa Buechler, et al.
Biomedicines|December 23, 2023
Exploring the Relationship between Plasma Adiponectin, Gender, and Underlying Diseases in Severe IllnessPatricia Mester, Ulrich Räth, Stephan Schmid, et al.
Viruses|July 29, 2023
Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19Patricia Mester, Pablo Amend, Stephan Schmid, et al.
Biomedicines|July 29, 2023
Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive InfectionsPablo Amend, Patricia Mester, Stephan Schmid, et al.
Cytokine|March 8, 2016
Pro-inflammatory chemokines CCL2, chemerin, IP-10 and RANTES in human serum during an oral lipid tolerance testAndreas Schmid, Margarita Bala, Stephanie Leszczak, et al.
Endocrinology|February 5, 2010
Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3Andrea Kopp, Christa Buechler, Margarita Bala, et al.
Diagnostics (Basel, Switzerland)|November 24, 2020
Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver InjuryGeorg Peschel, Jonathan Grimm, Karsten Gülow, et al.
Analytical Biochemistry|June 17, 2015
Evaluation of the specificity of four commercially available antibodies to alpha-syntrophinKristina Eisinger, Stanley C Froehner, Marvin E Adams, et al.
Cardiovascular Diabetology|February 14, 2007
Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseasesAndreas Schäffler, Martina Zeitoun, Hella Wobser, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 2011
In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1)Margarita Bala, Josefine Martin, Andrea Kopp, et al.
Pageof 23